Dadap, Baby Boy L.

HRN: 28-53-85  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/20/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
02/20/2026
02/27/2026
IV
130 Mg
Q 8 Hours
T/C Neonatal Sepsis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: